Inogen INGN
NASDAQ INGN
$5.27 +0.04 (+0.77%)
As of: Sep 9, 2026 · 3:59 PM EDT

Inogen (INGN) Other Non-Current Assets (2013 - 2026)

Inogen's (INGN) quarterly Other Non-Current Assets came in at $6.9 million in Q2 2026, up 2.86% year-over-year from $6.7 million in Q2 2025, and up 6.89% quarter-over-quarter from $6.5 million in Q1 2026.

Analysis

Inogen (INGN) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Inogen (INGN) has reported Other Non-Current Assets for 14 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 2.86% year-over-year to $6.9 million in Q2 2026; TTM through Jun 2026 was $6.9 million, a 2.86% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, down 25.73% from the prior year.
  • Other Non-Current Assets was $6.9 million for Q2 2026 at Inogen, up from $6.5 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $8.1 million in Q4 2024 and troughed at $2.1 million in Q2 2022.
  • A 5-year average of $4.5 million and a median of $3.8 million in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets slumped 36.61% in 2022 and jumped 111.27% in 2024, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $2.4 million in 2022, then surged by 56.44% to $3.8 million in 2023, then jumped by 111.27% to $8.1 million in 2024, then decreased by 25.73% to $6.0 million in 2025, then gained by 14.95% to $6.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $6.9 million (Q2 2026), $6.5 million (Q1 2026), and $6.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 4.32 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 616.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 273.70 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 215.10 Mn
10 Inogen 142.58 Mn 37.04 Mn 43.27 Mn 6.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.90 Mn
Mar 31, 2026 6.45 Mn
Dec 31, 2025 6.00 Mn
Sep 30, 2025 6.02 Mn
Jun 30, 2025 6.71 Mn
Mar 31, 2025 7.02 Mn
Dec 31, 2024 8.08 Mn
Sep 30, 2024 4.07 Mn
Jun 30, 2024 3.81 Mn
Mar 31, 2024 3.82 Mn
Dec 31, 2023 3.83 Mn
Sep 30, 2023 3.78 Mn
Jun 30, 2023 2.78 Mn
Mar 31, 2023 2.59 Mn
Dec 31, 2022 2.45 Mn
Sep 30, 2022 2.32 Mn
Jun 30, 2022 2.07 Mn
Mar 31, 2022 2.15 Mn
Dec 31, 2021 3.36 Mn
Sep 30, 2021 3.32 Mn